Yi-gan san restores behavioral alterations and a decrease of brain glutathione level in a mouse model of...

Area of Science:

• Neuroscience
• Pharmacology
• Traditional Chinese Medicine

Background:

• Schizophrenia is a neuropsychological disorder with complex etiology.
• Maternal infection during pregnancy is linked to an increased risk of schizophrenia in offspring.
• Traditional Chinese herbal medicine, yi-gan san, has a history of use in treating neuropsychological disorders.

Purpose of the Study:

• To evaluate the efficacy of yi-gan san in ameliorating schizophrenic symptoms using an established animal model.
• To investigate the impact of yi-gan san on specific behavioral and biochemical markers associated with schizophrenia.

Main Methods:

• An animal model of schizophrenia was established by injecting pregnant mice with polyinosinic-polycytidilic acid.
• Offspring mice received either yi-gan san or distilled water.
• Prepulse inhibition, methamphetamine sensitivity (open field tests), and whole brain total glutathione content were assessed.

Main Results:

• Yi-gan san treatment reversed deficits in prepulse inhibition and reduced methamphetamine hypersensitivity in model mice.
• Cognitive deficits observed in the model mice were ameliorated by yi-gan san.
• Reduced total glutathione levels in the brains of model mice were restored to normal by yi-gan san.

Conclusions:

• Yi-gan san demonstrates potential therapeutic effects on schizophrenia-like symptoms in an animal model.
• The herb may exert its benefits by restoring glutathione levels and improving cognitive function.
• Further research into yi-gan san as a treatment for schizophrenia is warranted.